<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03205280</url>
  </required_header>
  <id_info>
    <org_study_id>35RC16_8968 POCADIMS</org_study_id>
    <nct_id>NCT03205280</nct_id>
  </id_info>
  <brief_title>Clinical Decision Support System (CADIMS) for MS Diagnostic</brief_title>
  <acronym>POCADIMS</acronym>
  <official_title>Assessment of a Clinical Decision Support System (CADIMS) for Improving Multiple Sclerosis Diagnostic Accuracy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Neuro-Bretagne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de Recherche en Informatique et en Automatique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupement de Coopération Sanitaire e-Santé Bretagne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut de Recherche Technologique b&lt;&gt;com</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Background The results obtained in clinical research led to a new paradigm for the
           treatment of patients affected with multiple sclerosis (MS): &quot;no evidence of disease
           activity&quot;. This means having each patient monitored with high quality imaging. To this
           purpose, researchers have developed segmentation algorithms for automated reading of
           MRIs, facilitating longitudinal comparisons, and allowing an accurate assessment of the
           number and the volume of focal lesions. We have thus a powerful strategic biomarker for
           the treatment of MS.

           Due to the relevance of comparing over time the evolution of lesions (lesion load) and
           brain atrophy, the French Society of Neuroradiology edited standardized national
           recommendations. The MS French Observatory (OFSEP) has adopted these recommendations, in
           order to harmonize exams for all patients all over the country. At an international
           level as well, MRI have been put at the heart of the therapeutic strategy.

           Therefore, we need now to create the conditions able to implement, collect and analyze
           imaging data according to these recommendations.

           This is the meaning of the MUSIC project, which aims to develop and assess a
           standardized monitoring MRI control tool for therapeutic decision.

           CADIMS is this tool. It is based on an integration of several segmentation algorithms
           developed by INRIA and an image viewer developed by b&lt;&gt;com and included in a regional
           images-sharing server ETIAM Nexus. This tool is a help showing segmented brain T2
           lesions, gadolinium-enhanced T1 lesions and news T2 lesions appeared from the previous
           MRI exam, in a multicenter clinical context.

        2. Objective To evaluate the accuracy of MS lesions detection on cerebral MRI by comparing
           the CADIMS tool to the expert consensus.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance among the number of new T2 lesions, the total number of T2 lesions and the number of gadolinium enhanced lesions on brain MRIs identified by the CADIMS tool and by the expert consensus</measure>
    <time_frame>At the end of the enrollment</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Multiple Sclerosis, Relapsing-Remitting</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Relapsing-remitting multiple sclerosis patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 18 years-old

          -  Patient with relapsing-remitting multiple sclerosis, according to the 2010 Mc Donald's
             criteria

          -  EDSS&lt;4

          -  Disease duration &lt; 10 years

          -  To insure a clinical demand of 2 brain MRIs within 12 months of the installation of an
             immunomodulatory therapy

          -  MRI brain scanner acquired according to the OFSEP recommendations installation of an
             immunomodulatory therapy

        Exclusion Criteria:

          -  Progressive MS

          -  no consent of the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Christophe FERRE, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristell COAT</last_name>
    <phone>2 99 28 25 55</phone>
    <phone_ext>+33</phone_ext>
    <email>kristell.coat@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Direction de la Recherche et de l'Innovation</last_name>
    <phone>2 99 28 25 55</phone>
    <phone_ext>+33</phone_ext>
    <email>drc@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Régional et Universitaire de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Douraied BEN SALEM, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Douraied BEN SALEM, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurore JOURDRAIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Bretagne Sud</name>
      <address>
        <city>Lorient</city>
        <zip>56322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric LEVEQUE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eric LEVEQUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric SARTORI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Christophe FERRE, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Christophe FERRE, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles EDAN, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'imagerie médicale de la découverte</name>
      <address>
        <city>Saint-Malo</city>
        <zip>35400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jérome POIRIER</last_name>
    </contact>
    <investigator>
      <last_name>Jérome POIRIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Bretagne Atlantique</name>
      <address>
        <city>Vannes</city>
        <zip>56017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohammed BELKADI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mohammed BELKADI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe KASSIOTIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2017</study_first_submitted>
  <study_first_submitted_qc>June 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

